New Zealand markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
81.15-0.02 (-0.02%)
At close: 4:02PM EDT
81.07 -0.08 (-0.10%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5195.30B
Enterprise value 3213.24B
Trailing P/E 31.49
Forward P/E 111.47
PEG ratio (5-yr expected) 11.38
Price/sales (ttm)3.89
Price/book (mrq)5.87
Enterprise value/revenue 34.23
Enterprise value/EBITDA 717.69

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 37.87%
S&P500 52-week change 333.64%
52-week high 384.56
52-week low 368.44
50-day moving average 376.62
200-day moving average 375.82

Share statistics

Avg vol (3-month) 313.35M
Avg vol (10-day) 311.81M
Shares outstanding 52.53B
Implied shares outstanding 6N/A
Float 82.52B
% held by insiders 10.07%
% held by institutions 174.90%
Shares short (29 Sep 2021) 422.56M
Short ratio (29 Sep 2021) 41.71
Short % of float (29 Sep 2021) 40.89%
Short % of shares outstanding (29 Sep 2021) 40.89%
Shares short (prior month 30 Aug 2021) 427.42M

Dividends & splits

Forward annual dividend rate 42.6
Forward annual dividend yield 43.20%
Trailing annual dividend rate 32.52
Trailing annual dividend yield 33.10%
5-year average dividend yield 42.96
Payout ratio 4104.49%
Dividend date 306 Oct 2021
Ex-dividend date 413 Sep 2021
Last split factor 21048:1000
Last split date 302 Jun 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 11.06%
Operating margin (ttm)33.02%

Management effectiveness

Return on assets (ttm)11.47%
Return on equity (ttm)20.40%

Income statement

Revenue (ttm)50.38B
Revenue per share (ttm)19.91
Quarterly revenue growth (yoy)21.90%
Gross profit (ttm)34.57B
EBITDA 19.91B
Net income avi to common (ttm)6.21B
Diluted EPS (ttm)2.20
Quarterly earnings growth (yoy)-48.50%

Balance sheet

Total cash (mrq)8.59B
Total cash per share (mrq)3.39
Total debt (mrq)26.52B
Total debt/equity (mrq)79.43
Current ratio (mrq)1.31
Book value per share (mrq)13.15

Cash flow statement

Operating cash flow (ttm)10.86B
Levered free cash flow (ttm)8.58B